Published in J Clin Psychiatry on March 01, 2007
Treatment of Tardive Dyskinesia With Galantamine | NCT00164242
Movement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trial. Neurol Clin (2011) 0.97
Going up in smoke? A review of nAChRs-based treatment strategies for improving cognition in schizophrenia. Curr Pharm Des (2014) 0.86
The effects of galantamine on psychopathology in chronic stable schizophrenia. Clin Neuropharmacol (2009) 0.81
The case of galantamine: repurposing and late blooming of a cholinergic drug. Future Sci OA (2015) 0.75
Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry (2005) 5.72
Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol (2006) 5.48
Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Arch Gen Psychiatry (2005) 3.46
Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial. J Clin Psychiatry (2011) 2.88
Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial. Alcohol Clin Exp Res (2010) 2.70
Underuse of lung protective ventilation: analysis of potential factors to explain physician behavior. Crit Care Med (2006) 2.64
A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat. Proc Natl Acad Sci U S A (2002) 2.24
The dependability of alliance assessments: the alliance-outcome correlation is larger than you might think. J Consult Clin Psychol (2011) 2.00
A simple clinical predictive index for objective estimates of mortality in acute lung injury. Crit Care Med (2009) 1.91
Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence. Arch Intern Med (2005) 1.86
Attachment-based family therapy for adolescents with suicidal ideation: a randomized controlled trial. J Am Acad Child Adolesc Psychiatry (2010) 1.82
Preventing depression among early adolescents in the primary care setting: a randomized controlled study of the Penn Resiliency Program. J Abnorm Child Psychol (2006) 1.79
Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression. J Consult Clin Psychol (2009) 1.67
Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy. Blood (2008) 1.64
ANGPT2 genetic variant is associated with trauma-associated acute lung injury and altered plasma angiopoietin-2 isoform ratio. Am J Respir Crit Care Med (2011) 1.62
School-based prevention of depressive symptoms: A randomized controlled study of the effectiveness and specificity of the Penn Resiliency Program. J Consult Clin Psychol (2007) 1.57
Real-time quantitative PCR analysis can be used as a primary screen to identify patients with CML treated with imatinib who have BCR-ABL kinase domain mutations. Blood (2004) 1.57
Heterogeneous phenotypes of acute respiratory distress syndrome after major trauma. Ann Am Thorac Soc (2014) 1.57
Health-related quality of life in patients with pulmonary arterial hypertension. Respir Res (2005) 1.55
Therapists as fixed versus random effects-some statistical and conceptual issues: a comment on Siemer and Joormann (2003). Psychol Methods (2003) 1.52
Global TravEpiNet: a national consortium of clinics providing care to international travelers--analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009-2011. Clin Infect Dis (2011) 1.51
Regional distribution of wall thickness and failure properties of human abdominal aortic aneurysm. J Biomech (2005) 1.49
Antidepressant medications v. cognitive therapy in people with depression with or without personality disorder. Br J Psychiatry (2008) 1.44
A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol (2002) 1.39
The impact of development of acute lung injury on hospital mortality in critically ill trauma patients. Crit Care Med (2008) 1.38
Relation of depression diagnoses to 2-year outcomes in cocaine-dependent patients in a randomized continuing care study. Psychol Addict Behav (2002) 1.34
Long-term imatinib therapy promotes bone formation in CML patients. Blood (2007) 1.30
Treatment preferences affect the therapeutic alliance: implications for randomized controlled trials. J Consult Clin Psychol (2007) 1.28
Analgesic profile of intrathecal P2X(3) antisense oligonucleotide treatment in chronic inflammatory and neuropathic pain states in rats. Pain (2002) 1.27
Carotid artery dissection as a possible severe complication of pertussis in an adult: clinical case report and review. Clin Infect Dis (2002) 1.26
Lysophosphatidic acid receptors 1 and 2 play roles in regulation of vascular injury responses but not blood pressure. Circ Res (2008) 1.20
The psychometric properties of the MASC in a pediatric psychiatric sample. J Anxiety Disord (2006) 1.18
The alliance in motivational enhancement therapy and counseling as usual for substance use problems. J Consult Clin Psychol (2009) 1.16
Causal Mediation Analyses for Randomized Trials. Health Serv Outcomes Res Methodol (2008) 1.15
Prevention of depression in at-risk adolescents: longer-term effects. JAMA Psychiatry (2013) 1.15
Off-label recombinant factor VIIa use and thrombosis in children: a multi-center cohort study. J Pediatr (2010) 1.15
Unique and common mechanisms of change across cognitive and dynamic psychotherapies. J Consult Clin Psychol (2009) 1.14
Extreme nonresponse in cognitive therapy: can behavioral activation succeed where cognitive therapy fails? J Consult Clin Psychol (2007) 1.13
Retention in psychosocial treatment of cocaine dependence: predictors and impact on outcome. Am J Addict (2002) 1.12
The relation of patients' treatment preferences to outcome in a randomized clinical trial. Behav Ther (2007) 1.10
Measurement of in vivo BCR-ABL kinase inhibition to monitor imatinib-induced target blockade and predict response in chronic myeloid leukemia. J Clin Oncol (2007) 1.10
HIV risk reduction in the National Institute on Drug Abuse Cocaine Collaborative Treatment Study. J Acquir Immune Defic Syndr (2003) 1.09
Evaluation of disease-specific health-related quality of life in patients with pulmonary arterial hypertension. Respir Med (2008) 1.09
Motivational interviewing: a pilot test of active ingredients and mechanisms of change. Psychol Addict Behav (2012) 1.08
Progressive resistance to a selective serotonin reuptake inhibitor but not to cognitive therapy in the treatment of major depression. J Consult Clin Psychol (2007) 1.08
The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro. Bone (2004) 1.06
IL1RN coding variant is associated with lower risk of acute respiratory distress syndrome and increased plasma IL-1 receptor antagonist. Am J Respir Crit Care Med (2013) 1.03
Characterization of interleukin-4-stimulated nasal polyp fibroblasts. Am J Respir Cell Mol Biol (2003) 1.03
What aspects of treatment matter to the patient in the treatment of cocaine dependence? J Subst Abuse Treat (2004) 1.02
An alternative method of acute lung injury classification for use in observational studies. Chest (2010) 1.02
Long-term effects of brief acceptance and commitment therapy for psychosis. Behav Modif (2011) 1.02
Preventing depression: a randomized trial of interpersonal psychotherapy-adolescent skills training. Depress Anxiety (2010) 1.01
Wide variation in clinicians' assessment of New York Heart Association/World Health Organization functional class in patients with pulmonary arterial hypertension. Mayo Clin Proc (2009) 1.01
Topical tazarotene chemoprevention reduces Basal cell carcinoma number and size in Ptch1+/- mice exposed to ultraviolet or ionizing radiation. Cancer Res (2004) 1.01
Atomoxetine for treatment of marijuana dependence: a report on the efficacy and high incidence of gastrointestinal adverse events in a pilot study. Drug Alcohol Depend (2008) 1.00
Comparing smoking treatment programs for lighter smokers with and without a history of heavier smoking. J Subst Abuse Treat (2009) 0.99
A randomized controlled study of a web-based performance improvement system for substance abuse treatment providers. J Subst Abuse Treat (2010) 0.98
UNIVERSAL VERSUS ECONOMICALLY POLARIZED CHANGE IN AGE AT FIRST BIRTH: A FRENCH-BRITISH COMPARISON. Popul Dev Rev (2009) 0.97
African American race, obesity, and blood product transfusion are risk factors for acute kidney injury in critically ill trauma patients. J Crit Care (2012) 0.97
Sweet liking phenotype, alcohol craving and response to naltrexone treatment in alcohol dependence. Alcohol Alcohol (2009) 0.97
Depression precipitated by alcohol use in patients with co-occurring bipolar and substance use disorders. J Clin Psychiatry (2008) 0.96
The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE). J Bone Miner Res (2004) 0.96
Sensitive detection of KIT D816V in patients with mastocytosis. Clin Chem (2006) 0.95
Mother-child conflict and its moderating effects on depression outcomes in a preventive intervention for adolescent depression. J Clin Child Adolesc Psychol (2009) 0.95
REFINE-1, a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial With ATX-101, an Injectable Drug for Submental Fat Reduction. Dermatol Surg (2016) 0.94
One-year outcomes from the CASAWORKS for Families intervention for substance-abusing women on welfare. Eval Rev (2003) 0.94
Social, emotional, and academic competence among children who have had contact with child protective services: prevalence and stability estimates. J Am Acad Child Adolesc Psychiatry (2007) 0.93
Unipolar depression does not moderate responses to the Sweet Taste Test. Depress Anxiety (2010) 0.93
Fludarabine, cytarabine, granulocyte-colony stimulating factor and amsacrine: an effective salvage therapy option for acute myeloid leukemia at first relapse. Leuk Lymphoma (2012) 0.92
Effectiveness of vocational problem-solving skills on motivation and job-seeking action steps. Subst Use Misuse (2004) 0.92
Multilevel modeling of longitudinal data for psychotherapy researchers: I. The basics. Psychother Res (2009) 0.92
How many treatment sessions and patients are needed to create a stable score of adherence and competence in the treatment of cocaine dependence? Psychother Res (2012) 0.92
A generalizability theory analysis of group process ratings in the treatment of cocaine dependence. Psychother Res (2011) 0.91
Why do those who request smoking treatment fail to attend the first appointment? J Subst Abuse Treat (2007) 0.91
Dialectical behavior therapy (DBT) applied to college students: a randomized clinical trial. J Consult Clin Psychol (2012) 0.90
Comparison of embedded and isolated administrations of the California Psychological Inventory's Socialization subscale. Psychol Assess (2003) 0.90
A feasibility study of a web-based performance improvement system for substance abuse treatment providers. J Subst Abuse Treat (2007) 0.89
Combined medication and cognitive therapy for generalized anxiety disorder. J Anxiety Disord (2011) 0.89
Additional treatment services in a cocaine treatment study: level of services obtained and impact on outcome. Am J Addict (2008) 0.89
Renal safety of zoledronic acid with thalidomide in patients with myeloma: a pharmacokinetic and safety sub-study. BMC Clin Pharmacol (2008) 0.89
Dopamine transporter levels in cocaine dependent subjects. Drug Alcohol Depend (2008) 0.89
Multi-centre Phase II trial of the polyamine synthesis inhibitor SAM486A (CGP48664) in patients with metastatic melanoma. Invest New Drugs (2005) 0.89
A preliminary study of the effects of individual patient-level feedback in outpatient substance abuse treatment programs. J Subst Abuse Treat (2011) 0.87
Sequence of improvement in depressive symptoms across cognitive therapy and pharmacotherapy. J Affect Disord (2008) 0.87
Transitions to supported environments in England and Wales among elderly widowed and divorced women: the changing balance between co-residence with family and institutional care. J Women Aging (2003) 0.87
Manualized supportive-expressive psychotherapy versus nonmanualized community-delivered psychodynamic therapy for patients with personality disorders: bridging efficacy and effectiveness. Am J Psychiatry (2005) 0.86
Medication management and neuropsychological performance in Parkinson's disease. Clin Neuropsychol (2011) 0.86
Online illegal drug use information: an exploratory analysis of drug-related website viewing by adolescents. J Health Commun (2009) 0.86
Mediators of outcome of psychosocial treatments for cocaine dependence. J Consult Clin Psychol (2003) 0.86
MRI comparison of periprosthetic structures around zirconium knee prostheses and cobalt chrome prostheses. AJR Am J Roentgenol (2006) 0.86
Effects of family violence on psychopathology symptoms in children previously exposed to maltreatment. Child Dev (2008) 0.85
Work, permanent sickness and mortality risk: a prospective cohort study of England and Wales, 1971-2006. J Epidemiol Community Health (2010) 0.85
Selective serotonin reuptake inhibitor suppression of HIV infectivity and replication. Psychosom Med (2010) 0.84
Psychotherapies for Panic Disorder: A Tale of Two Sites. J Clin Psychiatry (2016) 0.84
Sudden gains in the treatment of generalized anxiety disorder. J Clin Psychol (2008) 0.83
Differential change in specific depressive symptoms during antidepressant medication or cognitive therapy. Behav Res Ther (2013) 0.83